Atlas Trials

OMEGA, Local Ablative Therapy in Oligometastatic NSCLC

Clinical trial NCT03827577 · UNKNOWN

Trial details

NCT number
NCT03827577
Sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Carcinoma, Non-Small-Cell Lung
Start date
2019-10-01
Primary completion
2022-03-01
Enrollment
195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.